Research conducted by the Tufts Center for the Study of Drug Development (CSDD) found that protocol complexity correlates with longer clinical study times and poorer patient recruitment. Therefore, drug development companies are working to increase clinical trial...
The Office for Human Research Protections discovered that a study involving premature babies did not disclose potential risks of the associated treatment with the involved families as indicated by a recent article published April 11, 2013 in the New York Times. The...
The frequency of dual enrollment, in which participants enroll in multiple clinical trials at the same time in order to benefit from increased healthcare or payments, is up for debate among the Association of Clinical Research Organizations (ACRO) and industry...
IHIF is hosting a lunch panel on April 16th, featuring Pearl’s Diana Caldwell and other industry professionals to discuss the impact of the service sector on life sciences in Indiana. What: IHIF Lunch Series Topic: “Indiana’s Life Science Service Sector” When:...
A new report from PricewaterhouseCoopers (PwC) found that the use of a risk-based algorithm to monitor clinical studies reduced the deployment of research associates and targeted more high-risk patients and sites. Although CROs and sponsors have been hesitant to use...
